nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP1A2—Imiquimod—skin cancer	0.0999	0.137	CbGbCtD
Terbinafine—CYP2C8—Vismodegib—skin cancer	0.0894	0.123	CbGbCtD
Terbinafine—CYP2C19—Vismodegib—skin cancer	0.075	0.103	CbGbCtD
Terbinafine—CYP2C9—Vismodegib—skin cancer	0.0624	0.0859	CbGbCtD
Terbinafine—CYP1A2—Vemurafenib—skin cancer	0.0547	0.0753	CbGbCtD
Terbinafine—CYP3A4—Temozolomide—skin cancer	0.0523	0.072	CbGbCtD
Terbinafine—CYP3A4—Imiquimod—skin cancer	0.0523	0.072	CbGbCtD
Terbinafine—CYP2D6—Vemurafenib—skin cancer	0.0451	0.0621	CbGbCtD
Terbinafine—CYP1A2—Dacarbazine—skin cancer	0.0419	0.0577	CbGbCtD
Terbinafine—CYP3A4—Vismodegib—skin cancer	0.0363	0.0499	CbGbCtD
Terbinafine—CYP2C8—Fluorouracil—skin cancer	0.0318	0.0437	CbGbCtD
Terbinafine—CYP3A4—Vemurafenib—skin cancer	0.0287	0.0395	CbGbCtD
Terbinafine—CYP1A2—Fluorouracil—skin cancer	0.0246	0.0338	CbGbCtD
Terbinafine—CYP2C9—Fluorouracil—skin cancer	0.0222	0.0305	CbGbCtD
Terbinafine—CYP3A4—Docetaxel—skin cancer	0.00984	0.0135	CbGbCtD
Terbinafine—SQLE—Sorafenib—Vismodegib—skin cancer	0.00727	1	CbGdCrCtD
Terbinafine—SQLE—hair follicle—skin cancer	0.00325	0.162	CbGeAlD
Terbinafine—SQLE—nipple—skin cancer	0.00221	0.11	CbGeAlD
Terbinafine—SQLE—mammalian vulva—skin cancer	0.00129	0.0641	CbGeAlD
Terbinafine—SQLE—female reproductive system—skin cancer	0.0011	0.0549	CbGeAlD
Terbinafine—CYP11A1—connective tissue—skin cancer	0.00103	0.051	CbGeAlD
Terbinafine—SQLE—head—skin cancer	0.000921	0.0459	CbGeAlD
Terbinafine—PTGS1—endothelium—skin cancer	0.000818	0.0407	CbGeAlD
Terbinafine—PTGS1—blood vessel—skin cancer	0.000754	0.0375	CbGeAlD
Terbinafine—CYP11A1—female reproductive system—skin cancer	0.000723	0.036	CbGeAlD
Terbinafine—CYP19A1—connective tissue—skin cancer	0.000666	0.0331	CbGeAlD
Terbinafine—SQLE—lymph node—skin cancer	0.000645	0.0321	CbGeAlD
Terbinafine—CYP1A2—nipple—skin cancer	0.000629	0.0313	CbGeAlD
Terbinafine—CYP11A1—head—skin cancer	0.000604	0.0301	CbGeAlD
Terbinafine—PTGS1—nipple—skin cancer	0.000545	0.0271	CbGeAlD
Terbinafine—Anorexia—Imiquimod—skin cancer	0.000472	0.00192	CcSEcCtD
Terbinafine—CYP19A1—female reproductive system—skin cancer	0.00047	0.0234	CbGeAlD
Terbinafine—Infestation NOS—Temozolomide—skin cancer	0.000465	0.00189	CcSEcCtD
Terbinafine—Infestation—Temozolomide—skin cancer	0.000465	0.00189	CcSEcCtD
Terbinafine—Hepatitis—Dactinomycin—skin cancer	0.000462	0.00188	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000461	0.00187	CcSEcCtD
Terbinafine—Body temperature increased—Vemurafenib—skin cancer	0.000459	0.00187	CcSEcCtD
Terbinafine—Pancytopenia—Fluorouracil—skin cancer	0.000457	0.00186	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000451	0.00183	CcSEcCtD
Terbinafine—Deafness—Docetaxel—skin cancer	0.000449	0.00182	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000447	0.00182	CcSEcCtD
Terbinafine—Hepatic failure—Docetaxel—skin cancer	0.000447	0.00182	CcSEcCtD
Terbinafine—Paraesthesia—Imiquimod—skin cancer	0.000445	0.00181	CcSEcCtD
Terbinafine—Hepatobiliary disease—Temozolomide—skin cancer	0.00044	0.00179	CcSEcCtD
Terbinafine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000439	0.00178	CcSEcCtD
Terbinafine—Alopecia—Bleomycin—skin cancer	0.000438	0.00178	CcSEcCtD
Terbinafine—Erythema multiforme—Dactinomycin—skin cancer	0.000437	0.00177	CcSEcCtD
Terbinafine—Dyspepsia—Imiquimod—skin cancer	0.000436	0.00177	CcSEcCtD
Terbinafine—Erythema—Bleomycin—skin cancer	0.000431	0.00175	CcSEcCtD
Terbinafine—Decreased appetite—Imiquimod—skin cancer	0.000431	0.00175	CcSEcCtD
Terbinafine—Infestation—Fluorouracil—skin cancer	0.000429	0.00174	CcSEcCtD
Terbinafine—Infestation NOS—Fluorouracil—skin cancer	0.000429	0.00174	CcSEcCtD
Terbinafine—Hypersensitivity—Vemurafenib—skin cancer	0.000428	0.00174	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000428	0.00174	CcSEcCtD
Terbinafine—Fatigue—Imiquimod—skin cancer	0.000427	0.00174	CcSEcCtD
Terbinafine—Visual disturbance—Docetaxel—skin cancer	0.000424	0.00172	CcSEcCtD
Terbinafine—Pain—Imiquimod—skin cancer	0.000424	0.00172	CcSEcCtD
Terbinafine—CYP11A1—lymph node—skin cancer	0.000423	0.021	CbGeAlD
Terbinafine—Dermatitis bullous—Docetaxel—skin cancer	0.00042	0.00171	CcSEcCtD
Terbinafine—Hepatitis—Temozolomide—skin cancer	0.000418	0.0017	CcSEcCtD
Terbinafine—Asthenia—Vemurafenib—skin cancer	0.000417	0.00169	CcSEcCtD
Terbinafine—Hypoaesthesia—Temozolomide—skin cancer	0.000416	0.00169	CcSEcCtD
Terbinafine—Pruritus—Vemurafenib—skin cancer	0.000411	0.00167	CcSEcCtD
Terbinafine—Connective tissue disorder—Temozolomide—skin cancer	0.000411	0.00167	CcSEcCtD
Terbinafine—Alopecia—Dactinomycin—skin cancer	0.000408	0.00166	CcSEcCtD
Terbinafine—Feeling abnormal—Imiquimod—skin cancer	0.000408	0.00166	CcSEcCtD
Terbinafine—Gastrointestinal pain—Imiquimod—skin cancer	0.000405	0.00165	CcSEcCtD
Terbinafine—Visual impairment—Temozolomide—skin cancer	0.000403	0.00164	CcSEcCtD
Terbinafine—Erythema—Dactinomycin—skin cancer	0.000402	0.00163	CcSEcCtD
Terbinafine—Agranulocytosis—Fluorouracil—skin cancer	0.0004	0.00163	CcSEcCtD
Terbinafine—Ill-defined disorder—Bleomycin—skin cancer	0.0004	0.00163	CcSEcCtD
Terbinafine—Anaemia—Bleomycin—skin cancer	0.000398	0.00162	CcSEcCtD
Terbinafine—Diarrhoea—Vemurafenib—skin cancer	0.000397	0.00161	CcSEcCtD
Terbinafine—Erythema multiforme—Temozolomide—skin cancer	0.000395	0.0016	CcSEcCtD
Terbinafine—Urticaria—Imiquimod—skin cancer	0.000393	0.0016	CcSEcCtD
Terbinafine—CYP19A1—head—skin cancer	0.000392	0.0195	CbGeAlD
Terbinafine—Abdominal pain—Imiquimod—skin cancer	0.000392	0.00159	CcSEcCtD
Terbinafine—Body temperature increased—Imiquimod—skin cancer	0.000392	0.00159	CcSEcCtD
Terbinafine—Eye disorder—Temozolomide—skin cancer	0.00039	0.00159	CcSEcCtD
Terbinafine—Tinnitus—Temozolomide—skin cancer	0.000389	0.00158	CcSEcCtD
Terbinafine—Malaise—Bleomycin—skin cancer	0.000389	0.00158	CcSEcCtD
Terbinafine—PTGS1—connective tissue—skin cancer	0.000387	0.0192	CbGeAlD
Terbinafine—Dizziness—Vemurafenib—skin cancer	0.000384	0.00156	CcSEcCtD
Terbinafine—Hypoaesthesia—Fluorouracil—skin cancer	0.000383	0.00156	CcSEcCtD
Terbinafine—Angiopathy—Temozolomide—skin cancer	0.000379	0.00154	CcSEcCtD
Terbinafine—Immune system disorder—Temozolomide—skin cancer	0.000377	0.00153	CcSEcCtD
Terbinafine—Cough—Bleomycin—skin cancer	0.000376	0.00153	CcSEcCtD
Terbinafine—Ill-defined disorder—Dactinomycin—skin cancer	0.000373	0.00152	CcSEcCtD
Terbinafine—Anaemia—Dactinomycin—skin cancer	0.000372	0.00151	CcSEcCtD
Terbinafine—Vomiting—Vemurafenib—skin cancer	0.000369	0.0015	CcSEcCtD
Terbinafine—Alopecia—Temozolomide—skin cancer	0.000369	0.0015	CcSEcCtD
Terbinafine—PTGS1—epithelium—skin cancer	0.000367	0.0183	CbGeAlD
Terbinafine—Chest pain—Bleomycin—skin cancer	0.000367	0.00149	CcSEcCtD
Terbinafine—Myalgia—Bleomycin—skin cancer	0.000367	0.00149	CcSEcCtD
Terbinafine—Abdominal pain upper—Docetaxel—skin cancer	0.000367	0.00149	CcSEcCtD
Terbinafine—Rash—Vemurafenib—skin cancer	0.000366	0.00149	CcSEcCtD
Terbinafine—Mental disorder—Temozolomide—skin cancer	0.000366	0.00149	CcSEcCtD
Terbinafine—Dermatitis—Vemurafenib—skin cancer	0.000366	0.00149	CcSEcCtD
Terbinafine—Hypersensitivity—Imiquimod—skin cancer	0.000365	0.00148	CcSEcCtD
Terbinafine—Headache—Vemurafenib—skin cancer	0.000364	0.00148	CcSEcCtD
Terbinafine—Erythema—Temozolomide—skin cancer	0.000364	0.00148	CcSEcCtD
Terbinafine—Discomfort—Bleomycin—skin cancer	0.000363	0.00147	CcSEcCtD
Terbinafine—Malaise—Dactinomycin—skin cancer	0.000363	0.00147	CcSEcCtD
Terbinafine—Cramp muscle—Docetaxel—skin cancer	0.000362	0.00147	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000362	0.00147	CcSEcCtD
Terbinafine—Nasopharyngitis—Docetaxel—skin cancer	0.000359	0.00146	CcSEcCtD
Terbinafine—Dysgeusia—Temozolomide—skin cancer	0.000356	0.00145	CcSEcCtD
Terbinafine—Asthenia—Imiquimod—skin cancer	0.000355	0.00144	CcSEcCtD
Terbinafine—Confusional state—Bleomycin—skin cancer	0.000355	0.00144	CcSEcCtD
Terbinafine—Anaphylactic shock—Bleomycin—skin cancer	0.000352	0.00143	CcSEcCtD
Terbinafine—Pruritus—Imiquimod—skin cancer	0.00035	0.00142	CcSEcCtD
Terbinafine—Infection—Bleomycin—skin cancer	0.00035	0.00142	CcSEcCtD
Terbinafine—PTGS1—skin of body—skin cancer	0.000349	0.0174	CbGeAlD
Terbinafine—Nausea—Vemurafenib—skin cancer	0.000345	0.0014	CcSEcCtD
Terbinafine—Thrombocytopenia—Bleomycin—skin cancer	0.000344	0.0014	CcSEcCtD
Terbinafine—Vision blurred—Temozolomide—skin cancer	0.000343	0.00139	CcSEcCtD
Terbinafine—Myalgia—Dactinomycin—skin cancer	0.000342	0.00139	CcSEcCtD
Terbinafine—Alopecia—Fluorouracil—skin cancer	0.00034	0.00138	CcSEcCtD
Terbinafine—Diarrhoea—Imiquimod—skin cancer	0.000339	0.00138	CcSEcCtD
Terbinafine—Discomfort—Dactinomycin—skin cancer	0.000338	0.00137	CcSEcCtD
Terbinafine—Ill-defined disorder—Temozolomide—skin cancer	0.000337	0.00137	CcSEcCtD
Terbinafine—CYP2C8—female reproductive system—skin cancer	0.000336	0.0167	CbGeAlD
Terbinafine—Anaemia—Temozolomide—skin cancer	0.000336	0.00137	CcSEcCtD
Terbinafine—Anorexia—Bleomycin—skin cancer	0.000335	0.00136	CcSEcCtD
Terbinafine—Erythema—Fluorouracil—skin cancer	0.000335	0.00136	CcSEcCtD
Terbinafine—Angioedema—Temozolomide—skin cancer	0.000332	0.00135	CcSEcCtD
Terbinafine—Pancytopenia—Docetaxel—skin cancer	0.00033	0.00134	CcSEcCtD
Terbinafine—Malaise—Temozolomide—skin cancer	0.000328	0.00133	CcSEcCtD
Terbinafine—Dizziness—Imiquimod—skin cancer	0.000328	0.00133	CcSEcCtD
Terbinafine—Vertigo—Temozolomide—skin cancer	0.000327	0.00133	CcSEcCtD
Terbinafine—Infection—Dactinomycin—skin cancer	0.000326	0.00132	CcSEcCtD
Terbinafine—Neutropenia—Docetaxel—skin cancer	0.000325	0.00132	CcSEcCtD
Terbinafine—Thrombocytopenia—Dactinomycin—skin cancer	0.000321	0.00131	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000321	0.0013	CcSEcCtD
Terbinafine—PTGS1—mammalian vulva—skin cancer	0.000318	0.0158	CbGeAlD
Terbinafine—Cough—Temozolomide—skin cancer	0.000317	0.00129	CcSEcCtD
Terbinafine—Paraesthesia—Bleomycin—skin cancer	0.000316	0.00128	CcSEcCtD
Terbinafine—Vision blurred—Fluorouracil—skin cancer	0.000316	0.00128	CcSEcCtD
Terbinafine—Vomiting—Imiquimod—skin cancer	0.000315	0.00128	CcSEcCtD
Terbinafine—Weight decreased—Docetaxel—skin cancer	0.000314	0.00128	CcSEcCtD
Terbinafine—Anorexia—Dactinomycin—skin cancer	0.000313	0.00127	CcSEcCtD
Terbinafine—Rash—Imiquimod—skin cancer	0.000312	0.00127	CcSEcCtD
Terbinafine—Dermatitis—Imiquimod—skin cancer	0.000312	0.00127	CcSEcCtD
Terbinafine—Headache—Imiquimod—skin cancer	0.00031	0.00126	CcSEcCtD
Terbinafine—Anaemia—Fluorouracil—skin cancer	0.00031	0.00126	CcSEcCtD
Terbinafine—Myalgia—Temozolomide—skin cancer	0.00031	0.00126	CcSEcCtD
Terbinafine—Arthralgia—Temozolomide—skin cancer	0.00031	0.00126	CcSEcCtD
Terbinafine—Infestation NOS—Docetaxel—skin cancer	0.000309	0.00126	CcSEcCtD
Terbinafine—Infestation—Docetaxel—skin cancer	0.000309	0.00126	CcSEcCtD
Terbinafine—Anxiety—Temozolomide—skin cancer	0.000309	0.00125	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000307	0.00125	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000307	0.00125	CcSEcCtD
Terbinafine—Discomfort—Temozolomide—skin cancer	0.000306	0.00124	CcSEcCtD
Terbinafine—Decreased appetite—Bleomycin—skin cancer	0.000306	0.00124	CcSEcCtD
Terbinafine—Dry mouth—Temozolomide—skin cancer	0.000303	0.00123	CcSEcCtD
Terbinafine—Jaundice—Docetaxel—skin cancer	0.000302	0.00123	CcSEcCtD
Terbinafine—Pain—Bleomycin—skin cancer	0.000301	0.00122	CcSEcCtD
Terbinafine—Confusional state—Temozolomide—skin cancer	0.000299	0.00122	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000299	0.00121	CcSEcCtD
Terbinafine—CYP2C9—female reproductive system—skin cancer	0.000299	0.0149	CbGeAlD
Terbinafine—Anaphylactic shock—Temozolomide—skin cancer	0.000297	0.00121	CcSEcCtD
Terbinafine—Infection—Temozolomide—skin cancer	0.000295	0.0012	CcSEcCtD
Terbinafine—Nausea—Imiquimod—skin cancer	0.000294	0.0012	CcSEcCtD
Terbinafine—Hepatobiliary disease—Docetaxel—skin cancer	0.000293	0.00119	CcSEcCtD
Terbinafine—Nervous system disorder—Temozolomide—skin cancer	0.000291	0.00118	CcSEcCtD
Terbinafine—Thrombocytopenia—Temozolomide—skin cancer	0.000291	0.00118	CcSEcCtD
Terbinafine—Feeling abnormal—Bleomycin—skin cancer	0.00029	0.00118	CcSEcCtD
Terbinafine—Agranulocytosis—Docetaxel—skin cancer	0.000289	0.00117	CcSEcCtD
Terbinafine—Skin disorder—Temozolomide—skin cancer	0.000288	0.00117	CcSEcCtD
Terbinafine—Chest pain—Fluorouracil—skin cancer	0.000285	0.00116	CcSEcCtD
Terbinafine—Myalgia—Fluorouracil—skin cancer	0.000285	0.00116	CcSEcCtD
Terbinafine—Decreased appetite—Dactinomycin—skin cancer	0.000285	0.00116	CcSEcCtD
Terbinafine—Fatigue—Dactinomycin—skin cancer	0.000283	0.00115	CcSEcCtD
Terbinafine—Anorexia—Temozolomide—skin cancer	0.000283	0.00115	CcSEcCtD
Terbinafine—Discomfort—Fluorouracil—skin cancer	0.000282	0.00115	CcSEcCtD
Terbinafine—Pain—Dactinomycin—skin cancer	0.000281	0.00114	CcSEcCtD
Terbinafine—Urticaria—Bleomycin—skin cancer	0.00028	0.00114	CcSEcCtD
Terbinafine—Body temperature increased—Bleomycin—skin cancer	0.000278	0.00113	CcSEcCtD
Terbinafine—Hepatitis—Docetaxel—skin cancer	0.000278	0.00113	CcSEcCtD
Terbinafine—Hypoaesthesia—Docetaxel—skin cancer	0.000276	0.00112	CcSEcCtD
Terbinafine—Confusional state—Fluorouracil—skin cancer	0.000276	0.00112	CcSEcCtD
Terbinafine—CYP19A1—lymph node—skin cancer	0.000275	0.0137	CbGeAlD
Terbinafine—Anaphylactic shock—Fluorouracil—skin cancer	0.000273	0.00111	CcSEcCtD
Terbinafine—Connective tissue disorder—Docetaxel—skin cancer	0.000273	0.00111	CcSEcCtD
Terbinafine—PTGS1—female reproductive system—skin cancer	0.000273	0.0136	CbGeAlD
Terbinafine—Infection—Fluorouracil—skin cancer	0.000272	0.0011	CcSEcCtD
Terbinafine—Feeling abnormal—Dactinomycin—skin cancer	0.00027	0.0011	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00027	0.0011	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000268	0.00109	CcSEcCtD
Terbinafine—Nervous system disorder—Fluorouracil—skin cancer	0.000268	0.00109	CcSEcCtD
Terbinafine—Thrombocytopenia—Fluorouracil—skin cancer	0.000268	0.00109	CcSEcCtD
Terbinafine—Visual impairment—Docetaxel—skin cancer	0.000268	0.00109	CcSEcCtD
Terbinafine—Paraesthesia—Temozolomide—skin cancer	0.000267	0.00108	CcSEcCtD
Terbinafine—Erythema multiforme—Docetaxel—skin cancer	0.000263	0.00107	CcSEcCtD
Terbinafine—Dyspepsia—Temozolomide—skin cancer	0.000261	0.00106	CcSEcCtD
Terbinafine—Anorexia—Fluorouracil—skin cancer	0.000261	0.00106	CcSEcCtD
Terbinafine—Eye disorder—Docetaxel—skin cancer	0.00026	0.00105	CcSEcCtD
Terbinafine—Abdominal pain—Dactinomycin—skin cancer	0.000259	0.00105	CcSEcCtD
Terbinafine—Body temperature increased—Dactinomycin—skin cancer	0.000259	0.00105	CcSEcCtD
Terbinafine—Hypersensitivity—Bleomycin—skin cancer	0.000259	0.00105	CcSEcCtD
Terbinafine—Decreased appetite—Temozolomide—skin cancer	0.000258	0.00105	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000256	0.00104	CcSEcCtD
Terbinafine—Fatigue—Temozolomide—skin cancer	0.000256	0.00104	CcSEcCtD
Terbinafine—Pain—Temozolomide—skin cancer	0.000254	0.00103	CcSEcCtD
Terbinafine—Asthenia—Bleomycin—skin cancer	0.000252	0.00103	CcSEcCtD
Terbinafine—Angiopathy—Docetaxel—skin cancer	0.000252	0.00102	CcSEcCtD
Terbinafine—Immune system disorder—Docetaxel—skin cancer	0.000251	0.00102	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000249	0.00101	CcSEcCtD
Terbinafine—Pruritus—Bleomycin—skin cancer	0.000249	0.00101	CcSEcCtD
Terbinafine—Paraesthesia—Fluorouracil—skin cancer	0.000246	0.000998	CcSEcCtD
Terbinafine—Alopecia—Docetaxel—skin cancer	0.000245	0.000998	CcSEcCtD
Terbinafine—Feeling abnormal—Temozolomide—skin cancer	0.000245	0.000994	CcSEcCtD
Terbinafine—Mental disorder—Docetaxel—skin cancer	0.000243	0.000989	CcSEcCtD
Terbinafine—Gastrointestinal pain—Temozolomide—skin cancer	0.000243	0.000986	CcSEcCtD
Terbinafine—Erythema—Docetaxel—skin cancer	0.000242	0.000983	CcSEcCtD
Terbinafine—Hypersensitivity—Dactinomycin—skin cancer	0.000242	0.000982	CcSEcCtD
Terbinafine—Dyspepsia—Fluorouracil—skin cancer	0.000241	0.000978	CcSEcCtD
Terbinafine—Decreased appetite—Fluorouracil—skin cancer	0.000238	0.000966	CcSEcCtD
Terbinafine—Dysgeusia—Docetaxel—skin cancer	0.000237	0.000962	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000236	0.000959	CcSEcCtD
Terbinafine—Urticaria—Temozolomide—skin cancer	0.000236	0.000958	CcSEcCtD
Terbinafine—Asthenia—Dactinomycin—skin cancer	0.000235	0.000957	CcSEcCtD
Terbinafine—Abdominal pain—Temozolomide—skin cancer	0.000235	0.000953	CcSEcCtD
Terbinafine—Body temperature increased—Temozolomide—skin cancer	0.000235	0.000953	CcSEcCtD
Terbinafine—Pain—Fluorouracil—skin cancer	0.000234	0.00095	CcSEcCtD
Terbinafine—Muscle spasms—Docetaxel—skin cancer	0.000233	0.000945	CcSEcCtD
Terbinafine—PTGS1—head—skin cancer	0.000228	0.0113	CbGeAlD
Terbinafine—CYP3A4—female reproductive system—skin cancer	0.000228	0.0113	CbGeAlD
Terbinafine—Feeling abnormal—Fluorouracil—skin cancer	0.000225	0.000916	CcSEcCtD
Terbinafine—Diarrhoea—Dactinomycin—skin cancer	0.000225	0.000912	CcSEcCtD
Terbinafine—CYP2D6—female reproductive system—skin cancer	0.000224	0.0112	CbGeAlD
Terbinafine—Vomiting—Bleomycin—skin cancer	0.000224	0.000909	CcSEcCtD
Terbinafine—Anaemia—Docetaxel—skin cancer	0.000224	0.000908	CcSEcCtD
Terbinafine—Rash—Bleomycin—skin cancer	0.000222	0.000901	CcSEcCtD
Terbinafine—Dermatitis—Bleomycin—skin cancer	0.000222	0.000901	CcSEcCtD
Terbinafine—Hypersensitivity—Temozolomide—skin cancer	0.000219	0.000889	CcSEcCtD
Terbinafine—Urticaria—Fluorouracil—skin cancer	0.000217	0.000883	CcSEcCtD
Terbinafine—Body temperature increased—Fluorouracil—skin cancer	0.000216	0.000878	CcSEcCtD
Terbinafine—Asthenia—Temozolomide—skin cancer	0.000213	0.000865	CcSEcCtD
Terbinafine—Cough—Docetaxel—skin cancer	0.000211	0.000858	CcSEcCtD
Terbinafine—Pruritus—Temozolomide—skin cancer	0.00021	0.000853	CcSEcCtD
Terbinafine—Nausea—Bleomycin—skin cancer	0.000209	0.000849	CcSEcCtD
Terbinafine—Vomiting—Dactinomycin—skin cancer	0.000209	0.000848	CcSEcCtD
Terbinafine—Rash—Dactinomycin—skin cancer	0.000207	0.000841	CcSEcCtD
Terbinafine—Arthralgia—Docetaxel—skin cancer	0.000206	0.000837	CcSEcCtD
Terbinafine—Myalgia—Docetaxel—skin cancer	0.000206	0.000837	CcSEcCtD
Terbinafine—Chest pain—Docetaxel—skin cancer	0.000206	0.000837	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000204	0.000831	CcSEcCtD
Terbinafine—Diarrhoea—Temozolomide—skin cancer	0.000203	0.000825	CcSEcCtD
Terbinafine—Hypersensitivity—Fluorouracil—skin cancer	0.000201	0.000819	CcSEcCtD
Terbinafine—Dry mouth—Docetaxel—skin cancer	0.000201	0.000818	CcSEcCtD
Terbinafine—Confusional state—Docetaxel—skin cancer	0.000199	0.000809	CcSEcCtD
Terbinafine—Anaphylactic shock—Docetaxel—skin cancer	0.000197	0.000802	CcSEcCtD
Terbinafine—Dizziness—Temozolomide—skin cancer	0.000196	0.000797	CcSEcCtD
Terbinafine—Infection—Docetaxel—skin cancer	0.000196	0.000797	CcSEcCtD
Terbinafine—Nausea—Dactinomycin—skin cancer	0.000195	0.000792	CcSEcCtD
Terbinafine—Nervous system disorder—Docetaxel—skin cancer	0.000194	0.000787	CcSEcCtD
Terbinafine—Pruritus—Fluorouracil—skin cancer	0.000193	0.000786	CcSEcCtD
Terbinafine—Thrombocytopenia—Docetaxel—skin cancer	0.000193	0.000785	CcSEcCtD
Terbinafine—Skin disorder—Docetaxel—skin cancer	0.000192	0.000779	CcSEcCtD
Terbinafine—Vomiting—Temozolomide—skin cancer	0.000189	0.000767	CcSEcCtD
Terbinafine—Anorexia—Docetaxel—skin cancer	0.000188	0.000764	CcSEcCtD
Terbinafine—CYP2D6—head—skin cancer	0.000187	0.00932	CbGeAlD
Terbinafine—Rash—Temozolomide—skin cancer	0.000187	0.00076	CcSEcCtD
Terbinafine—Diarrhoea—Fluorouracil—skin cancer	0.000187	0.00076	CcSEcCtD
Terbinafine—Dermatitis—Temozolomide—skin cancer	0.000187	0.00076	CcSEcCtD
Terbinafine—Headache—Temozolomide—skin cancer	0.000186	0.000756	CcSEcCtD
Terbinafine—Dizziness—Fluorouracil—skin cancer	0.000181	0.000735	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00018	0.000731	CcSEcCtD
Terbinafine—Paraesthesia—Docetaxel—skin cancer	0.000177	0.00072	CcSEcCtD
Terbinafine—Nausea—Temozolomide—skin cancer	0.000176	0.000716	CcSEcCtD
Terbinafine—Vomiting—Fluorouracil—skin cancer	0.000174	0.000707	CcSEcCtD
Terbinafine—Dyspepsia—Docetaxel—skin cancer	0.000174	0.000706	CcSEcCtD
Terbinafine—Rash—Fluorouracil—skin cancer	0.000172	0.000701	CcSEcCtD
Terbinafine—Dermatitis—Fluorouracil—skin cancer	0.000172	0.0007	CcSEcCtD
Terbinafine—Decreased appetite—Docetaxel—skin cancer	0.000172	0.000697	CcSEcCtD
Terbinafine—Headache—Fluorouracil—skin cancer	0.000171	0.000696	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00017	0.000692	CcSEcCtD
Terbinafine—Fatigue—Docetaxel—skin cancer	0.00017	0.000691	CcSEcCtD
Terbinafine—Pain—Docetaxel—skin cancer	0.000169	0.000686	CcSEcCtD
Terbinafine—Feeling abnormal—Docetaxel—skin cancer	0.000163	0.000661	CcSEcCtD
Terbinafine—Nausea—Fluorouracil—skin cancer	0.000162	0.00066	CcSEcCtD
Terbinafine—Gastrointestinal pain—Docetaxel—skin cancer	0.000161	0.000656	CcSEcCtD
Terbinafine—PTGS1—lymph node—skin cancer	0.00016	0.00794	CbGeAlD
Terbinafine—Abdominal pain—Docetaxel—skin cancer	0.000156	0.000634	CcSEcCtD
Terbinafine—Body temperature increased—Docetaxel—skin cancer	0.000156	0.000634	CcSEcCtD
Terbinafine—Hypersensitivity—Docetaxel—skin cancer	0.000145	0.000591	CcSEcCtD
Terbinafine—Asthenia—Docetaxel—skin cancer	0.000142	0.000575	CcSEcCtD
Terbinafine—Pruritus—Docetaxel—skin cancer	0.00014	0.000567	CcSEcCtD
Terbinafine—Diarrhoea—Docetaxel—skin cancer	0.000135	0.000549	CcSEcCtD
Terbinafine—Dizziness—Docetaxel—skin cancer	0.000131	0.00053	CcSEcCtD
Terbinafine—Vomiting—Docetaxel—skin cancer	0.000125	0.00051	CcSEcCtD
Terbinafine—Rash—Docetaxel—skin cancer	0.000124	0.000506	CcSEcCtD
Terbinafine—Dermatitis—Docetaxel—skin cancer	0.000124	0.000505	CcSEcCtD
Terbinafine—Headache—Docetaxel—skin cancer	0.000124	0.000502	CcSEcCtD
Terbinafine—Nausea—Docetaxel—skin cancer	0.000117	0.000476	CcSEcCtD
